ALLO vs XOM · rev $22.0K vs P/E 24, rev $332.24B
Allogene Therapeutics Inc (ALLO) versus Exxon Mobil Corp (XOM) — a side-by-side from cached financials, not a winner call.
Allogene Therapeutics Inc (ALLO) is a biotechnology company listed on US.
Exxon Mobil Corp (XOM) is a oil & gas integrated company listed on NYSE. It is led by Darren Woods.
Latest reported ALLO revenue for 2024-12-31 was $22.0K. Net income was -$257.6M. Revenue was down 76.8% from 2023-12-31 to 2024-12-31. ALLO currently screens at market cap $258.1M.
Latest reported XOM revenue for 2025-12-31 was $332.24B. Net income was $28.84B. Revenue was down 5.0% from 2024-12-31 to 2025-12-31. XOM currently screens at market cap $583.36B and trailing P/E 23.7.
ALLO currently screens at market cap $258.1M. XOM currently screens at market cap $583.36B and trailing P/E 23.7.
Not investment advice. Open the ALLO and XOM stock pages for the full models.
Not investment advice.